Comparison of the estimated prevalence of mood and/or anxiety disorders in Canada between self-report and administrative data

Abstract

The overall narrowing of differences over time reflects a convergence of information regarding the prevalence of mood and/or anxiety disorders trends between self-report and administrative data sources. While the administrative data-based prevalences remained relatively stable, the self-reported prevalences increased over time. These observations may reflect positive societal changes in the perceptions of mental health (declining stigma) and/or increasing mental health literacy. Additional research using non-ecological data is required to further our understanding of the observed findings and trends, including a data linkage exercise permitting a comparison of prevalence estimates and population characteristics from these two data sources both separately and merged.

Anxiety, Depression, Physical Activity and Quality of Life in Student Physical Therapists: A Cross-sectional Study

“…Lloyd et al reported high mean anxiety scores when compared to the general population in both dental and medical students [16,17]. O'Donell et al reported prevalence of self-reported anxiety to be 9.4 % identified from Canadian community health Survey System [18]. According to our results, 40.5% of the student physical therapistn=64) had mild, moderate or severe anxiety, which is higher compared to reported general population prevalence.…”

Using Canadian administrative health data to measure the health of caregivers of children with and without health problems: A demonstration of feasibility.

“…Our estimates of the prevalence of various maternal chronic conditions are in the range of estimates from other studies using survey and administrative data. For example, our rates of diabetes, heart disease, and mood or anxiety disorder are similar to the estimates found using health surveillance data [34][35][36]. However, some survey-based estimates are higher than those found in our study.…”

A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database

“…Indeed, excluding epilepsy [63], gabapentinoids are prescribed to treat disorders that are more typically identified in female individuals, including chronic/neuropathic pain [64], generalized anxiety disorder [65], fibromyalgia [66], restless legs syndrome [67], migraine [68] and, of course, vasomotor symptoms of menopause.…”